IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Lunate Capital Ltd

Q4 2025 Holdings

Filed 2026-01-23 | 6 holdings | $264.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Revolution Medicines Inc(RVMD)COM76155X100$174.9M2,196,20066.2%
Sailpoint Inc(SAIL)COM78781J109$60.7M3,000,00023.0%
Lineage Inc(LINE)COM53566V106$21.0M600,0007.9%
Neumora Therapeutics Inc.(NMRA)COM640979100$3.8M2,124,1431.4%
Navan Inc(NAVN)CL A639193101$3.4M200,0001.3%
Revolution Medicines Inc(RVMDW)*W EXP 12/17/20276155X118$423.0K450,0000.2%